Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qingyang Xu, Joonhyuk Cho, Zied Ben Chaouch & Andrew W. Lo. (2023) Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspective. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 281-288.
Read now
Read now
Tasnime Hamdeni & Soufiane Gasmi. (2022) A proportional-hazards model for survival analysis and long-term survivors modeling: application to amyotrophic lateral sclerosis data. Journal of Applied Statistics 49:3, pages 694-708.
Read now
Read now
Kinjal Thakor, Shelly Naud, Diantha Howard, Rup Tandan & Waqar Waheed. (2021) Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 360-367.
Read now
Read now
Nimish J. Thakore, Brittany R. Lapin & Erik P. Pioro. (2020) Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 140-143.
Read now
Read now
Articles from other publishers (21)
Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Weiqiang Zhou, Jean-Philippe Richard, Arens Taga, Pan Li, Xiaobo Mao, Nicholas J. Maragakis & Mingyao Ying. (2022) Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Molecular Neurodegeneration 17:1.
Crossref
Crossref
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, Magdalena Sawicka, Marta Myśliwiec, Kenneth V. Honn, Stephanie C. Tucker & Marek Z. Wojtukiewicz. (2022) Is depression the missing link between inflammatory mediators and cancer?. Pharmacology & Therapeutics 240, pages 108293.
Crossref
Crossref
Giada Crescioli, Marco Finocchietti, Silvia Cascini, Olga Paoletti, David Franchini, Emiliano Cappello, Giulia Valdiserra, Francesco Sciancalepore, Maria Grazia Celani, Marco Tuccori, Alfredo Vannacci, Niccolò Lombardi & Ursula Kirchmayer. (2022) Riluzole use in presence of contraindications in adults affected by amyotrophic lateral sclerosis and its off-label use in other motor neuron diseases: Findings from an Italian multicentre study (the CAESAR project). Frontiers in Drug Safety and Regulation 2.
Crossref
Crossref
Maria Argente-Pla, Katherine Garcia-Malpartida, Andrea Micó-García, Silvia Martín-Sanchis & Juan Francisco Merino-Torres. 2022. Dysphagia - New Advances. Dysphagia - New Advances.
André D. J. Mckenzie, Taylor R. Garrett, Eryn L. Werry & Michael Kassiou. (2022)
Purinergic P2X
7
Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis
. ACS Chemical Neuroscience 13:10, pages 1479-1490.
Crossref
Crossref
Mónica Povedano, Andrés Paipa, Miquel Barceló, Michael K. Woodward, Sandra Ortega, Raúl Domínguez, Maria Esperança Aragonés, Raquel Horrillo, Montserrat Costa & Antonio Páez. (2021) Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study. Neurological Sciences 43:5, pages 3211-3221.
Crossref
Crossref
Ammar Aljabri, Alhussain Halawani, Ghassan Bin Lajdam, Suhail Labban, Samah Alshehri & Razaz Felemban. (2021) The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials. Frontiers in Neurology 12.
Crossref
Crossref
Jing Zhao, Claire H. Stevens, Andrew W. Boyd, Lezanne Ooi & Perry F. Bartlett. (2021) Role of EphA4 in Mediating Motor Neuron Death in MND. International Journal of Molecular Sciences 22:17, pages 9430.
Crossref
Crossref
Heather M. Wilkins, Mazen M. Dimachkie & Abdulbaki Agbas. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis
105
120
.
Oihane Pikatza-Menoio, Amaia Elicegui, Xabier Bengoetxea, Neia Naldaiz-Gastesi, Adolfo López de Munain, Gorka Gerenu, Francisco Javier Gil-Bea & Sonia Alonso-Martín. (2021) The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. Journal of Personalized Medicine 11:7, pages 671.
Crossref
Crossref
Mónica Povedano Panades, Philippe Couratier, Katie Sidle, Gianni Sorarù, Georgios Tsivgoulis & Albert C. Ludolph. (2021) Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Jasmine Harley, Benjamin E. Clarke & Rickie Patani. (2021) The Interplay of RNA Binding Proteins, Oxidative Stress and Mitochondrial Dysfunction in ALS. Antioxidants 10:4, pages 552.
Crossref
Crossref
Monika Pichla, Grzegorz Bartosz & Izabela Sadowska-Bartosz. (2020) The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2020, pages 1-11.
Crossref
Crossref
Serge Mignani, Xiangyang Shi, João Rodrigues, René Roy, Ángeles Muñoz-Fernández, Valentin Ceña & Jean-Pierre Majoral. (2020) Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis. Bioconjugate Chemistry 31:9, pages 2060-2071.
Crossref
Crossref
Khalil Mallah, Christine Couch, Davis M. Borucki, Amer Toutonji, Mohammed Alshareef & Stephen Tomlinson. (2020) Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?. Frontiers in Immunology 11.
Crossref
Crossref
Giuseppe Colombo, Roberta Artico & Daniele Barbareschi. (2020) Riluzole Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis: Texture and Compatibility with Food Thickeners Evaluation. J — Multidisciplinary Scientific Journal 3:3, pages 275-288.
Crossref
Crossref
Serge Mignani, Jean-Pierre Majoral, Jean-François Desaphy & Giovanni Lentini. (2020) From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. Molecules 25:15, pages 3320.
Crossref
Crossref
Humberto Foyaca Sibat & Lourdes de Fátima Ibañez Valdés. 2020. Novel Aspects on Motor Neuron Disease. Novel Aspects on Motor Neuron Disease.
Agnese Gugliandolo, Placido Bramanti & Emanuela Mazzon. (2019) Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?. Stem Cells International 2019, pages 1-16.
Crossref
Crossref
Henry Knipe & Frank Gaillard. 2005. Radiopaedia.org. Radiopaedia.org.
Nunung Nugroho & Albert Setiawan. (1970) Diagnostic Approach in Isolated Bulbar Amyotrophic Lateral Sclerosis: A Case Report. Indonesian Journal of Physical Medicine and Rehabilitation 10:01, pages 37-45.
Crossref
Crossref